Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries.
EClinicalMedicine(2020)
摘要
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
更多查看译文
关键词
Human papillomavirus,Quadrivalent hpv vaccine,Cervical intraepithelial neoplasia,Long-term follow-up
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要